Cargando…

The association between maternal HbA1c and adverse outcomes in gestational diabetes

BACKGROUND: The role of HbA1c in women with gestational diabetes mellitus (GDM) is still unclear, particularly in the Asian population. AIM: To investigate the association between HbA1c levels and adverse outcomes considering maternal age, pre-pregnancy body mass index (BMI), and gestational weight...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhuza, Marie Parfaite Uwimana, Zhang, Lixia, Wu, Qi, Qi, Lu, Chen, Danqing, Liang, Zhaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060951/
https://www.ncbi.nlm.nih.gov/pubmed/37008898
http://dx.doi.org/10.3389/fendo.2023.1105899
_version_ 1785017193872752640
author Muhuza, Marie Parfaite Uwimana
Zhang, Lixia
Wu, Qi
Qi, Lu
Chen, Danqing
Liang, Zhaoxia
author_facet Muhuza, Marie Parfaite Uwimana
Zhang, Lixia
Wu, Qi
Qi, Lu
Chen, Danqing
Liang, Zhaoxia
author_sort Muhuza, Marie Parfaite Uwimana
collection PubMed
description BACKGROUND: The role of HbA1c in women with gestational diabetes mellitus (GDM) is still unclear, particularly in the Asian population. AIM: To investigate the association between HbA1c levels and adverse outcomes considering maternal age, pre-pregnancy body mass index (BMI), and gestational weight gain (GWG) in women with GDM. METHOD: A retrospective study included 2048 women with GDM and singleton live births. Using logistic regression, the associations between HbA1c and adverse pregnancy outcomes were assessed. RESULT: Compared to women with HbA1c ≤ 5.0%, HbA1c was significantly associated with macrosomia (aOR 2.63,95%CI1.61,4.31), pregnancy-induced hypertension (PIH, aOR 2.56,95%CI1.57,4.19), preterm birth (aOR 1.64,95%CI 1.05,2.55), and primary Cesarean section (primary C-section, aOR1.49,95%CI1.09,2.03) in GDM women with HbA1c ≥5.5% while significantly associated with PIH (aOR 1.91,95%CI1.24,2.94) in women with HbA1c 5.1-5.4%. The associations between HbA1c and adverse outcomes varied with maternal age, pre-pregnancy BMI, and GWG. In women aged ≤29 years, there’s significant association between HbA1c and primary C-section when HbA1c was 5.1-5.4% and ≥5.5%. In women aged 29-34 years and HbA1c ≥5.5%, HbA1c was significantly associated with macrosomia. In women aged ≥35 years, there’s significant association between HbA1c and preterm birth when HbA1c was 5.1-5.4% and macrosomia and PIH when HbA1c ≥5.5%. In pre-pregnant normal-weight women, HbA1c was significantly associated with macrosomia, preterm birth, primary C-section, and PIH when HbA1c ≥5.5% while HbA1c was significantly associated with PIH when HbA1c was 5.1-5.4% . In pre-pregnant underweight women with HbA1c 5.1-5.4%, HbA1c was significantly associated with primary C-section. HbA1c was significantly associated with macrosomia among women with inadequate GWG or excess GWG and HbA1c≥5.5%. In women with adequate GWG, there’s significant association between HbA1c and PIH when HbA1c was 5.1-5.4% and ≥5.5% . CONCLUSION: Conclusively, HbA1c at the time of diagnosis is significantly associated with macrosomia, preterm birth, PIH, and primary C-section in Chinese women with GDM.
format Online
Article
Text
id pubmed-10060951
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100609512023-03-31 The association between maternal HbA1c and adverse outcomes in gestational diabetes Muhuza, Marie Parfaite Uwimana Zhang, Lixia Wu, Qi Qi, Lu Chen, Danqing Liang, Zhaoxia Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The role of HbA1c in women with gestational diabetes mellitus (GDM) is still unclear, particularly in the Asian population. AIM: To investigate the association between HbA1c levels and adverse outcomes considering maternal age, pre-pregnancy body mass index (BMI), and gestational weight gain (GWG) in women with GDM. METHOD: A retrospective study included 2048 women with GDM and singleton live births. Using logistic regression, the associations between HbA1c and adverse pregnancy outcomes were assessed. RESULT: Compared to women with HbA1c ≤ 5.0%, HbA1c was significantly associated with macrosomia (aOR 2.63,95%CI1.61,4.31), pregnancy-induced hypertension (PIH, aOR 2.56,95%CI1.57,4.19), preterm birth (aOR 1.64,95%CI 1.05,2.55), and primary Cesarean section (primary C-section, aOR1.49,95%CI1.09,2.03) in GDM women with HbA1c ≥5.5% while significantly associated with PIH (aOR 1.91,95%CI1.24,2.94) in women with HbA1c 5.1-5.4%. The associations between HbA1c and adverse outcomes varied with maternal age, pre-pregnancy BMI, and GWG. In women aged ≤29 years, there’s significant association between HbA1c and primary C-section when HbA1c was 5.1-5.4% and ≥5.5%. In women aged 29-34 years and HbA1c ≥5.5%, HbA1c was significantly associated with macrosomia. In women aged ≥35 years, there’s significant association between HbA1c and preterm birth when HbA1c was 5.1-5.4% and macrosomia and PIH when HbA1c ≥5.5%. In pre-pregnant normal-weight women, HbA1c was significantly associated with macrosomia, preterm birth, primary C-section, and PIH when HbA1c ≥5.5% while HbA1c was significantly associated with PIH when HbA1c was 5.1-5.4% . In pre-pregnant underweight women with HbA1c 5.1-5.4%, HbA1c was significantly associated with primary C-section. HbA1c was significantly associated with macrosomia among women with inadequate GWG or excess GWG and HbA1c≥5.5%. In women with adequate GWG, there’s significant association between HbA1c and PIH when HbA1c was 5.1-5.4% and ≥5.5% . CONCLUSION: Conclusively, HbA1c at the time of diagnosis is significantly associated with macrosomia, preterm birth, PIH, and primary C-section in Chinese women with GDM. Frontiers Media S.A. 2023-03-16 /pmc/articles/PMC10060951/ /pubmed/37008898 http://dx.doi.org/10.3389/fendo.2023.1105899 Text en Copyright © 2023 Muhuza, Zhang, Wu, Qi, Chen and Liang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Muhuza, Marie Parfaite Uwimana
Zhang, Lixia
Wu, Qi
Qi, Lu
Chen, Danqing
Liang, Zhaoxia
The association between maternal HbA1c and adverse outcomes in gestational diabetes
title The association between maternal HbA1c and adverse outcomes in gestational diabetes
title_full The association between maternal HbA1c and adverse outcomes in gestational diabetes
title_fullStr The association between maternal HbA1c and adverse outcomes in gestational diabetes
title_full_unstemmed The association between maternal HbA1c and adverse outcomes in gestational diabetes
title_short The association between maternal HbA1c and adverse outcomes in gestational diabetes
title_sort association between maternal hba1c and adverse outcomes in gestational diabetes
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060951/
https://www.ncbi.nlm.nih.gov/pubmed/37008898
http://dx.doi.org/10.3389/fendo.2023.1105899
work_keys_str_mv AT muhuzamarieparfaiteuwimana theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT zhanglixia theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT wuqi theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT qilu theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT chendanqing theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT liangzhaoxia theassociationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT muhuzamarieparfaiteuwimana associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT zhanglixia associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT wuqi associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT qilu associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT chendanqing associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes
AT liangzhaoxia associationbetweenmaternalhba1candadverseoutcomesingestationaldiabetes